Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study
José Luis Fernández Martín(Universidad de Oviedo), Jorge B. Cannata‐Andía(Universidad de Oviedo), Diego Rodrı́guez-Puyol(Universidad de Alcalá), José Emilio Hernández Sánchez(Hospital Universitario Ramón y Cajal), Aníbal Ferreira(Hospital Vila Franca de Xira), Gérard M. London(Unknown), Willem Jan W. Bos(St. Antonius Ziekenhuis), Markus Ketteler(Robert Bosch Hospital), José Luis Górriz(Universitat de València), Adrian Covic, Pablo Martínez‐Camblor(Dartmouth College), Francesco Locatelli(Alessandro Manzoni Hospital), Jürgen Floege(RWTH Aachen University), María Paula Dionisi(Universidad de Oviedo), Minerva Rodríguez-García(Universidad de Oviedo)
Cited by 201
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
|Kidney International|2017|998
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809